What is The Ensign Group's latest dividend and current dividend yield?

Did The Ensign Group beat or miss consensus estimates last quarter?

What factors drove the changes in The Ensign Group's revenue and profit?

What were the key takeaways from The Ensign Group’s earnings call?

What is the revenue and EPS growth rate for The Ensign Group year over year?

What is the market's earnings forecast for The Ensign Group next quarter?

What guidance did The Ensign Group's management provide for the next earnings period?

What does The Ensign Group do and what are its main business segments?

- **Revenue growth accelerates**: Q4 2025 revenue up 20.2% YoY, driven by 8.5% skilled day growth and 15.7% Medicare revenue increase.
- **Clinical leadership**: Same-store operations outperform peers by 24% in CMS surveys, with 5-star ratings 19% higher than competitors.
- **Acquisition and construction surge**: 17 new operations added in Q4, 12 new construction projects underway, and 2026 guidance reflects 14.3% EPS growth**
- **Financial strength**: $564 million cash flow, 1.77x debt/EBITDA, and $1 billion+ dry powder for future investments.
- **Strategic initiatives**: Behavioral health expansion, AI-driven efficiency, and replacement facilities to maintain market dominance.

**【CEO Summary Section】**
- **Record financial and clinical performance**: Q4 2025 revenue grew 20.2% YoY to $1.4 billion, driven by 8.5% and 10% increases in skilled days for same-store and transitioning operations. Medicare revenue rose 15.7% and 11.3%, respectively.
- **Clinical excellence**: Same-store operations outperformed peers by 24% in CMS survey results and maintained a 19% advantage in 4- and 5-star ratings. Occupancy reached all-time highs of 83.8% (same-store) and 84.9% (transitioning).
- **Acquisition momentum**: 17 new operations added in Q4, including 1,371 beds across 7 states. 2026 guidance projects $7.41-$7.61 EPS and $5.77-$5.84 billion revenue, reflecting 14.3% EPS growth.
- **Long-term growth**: 21.7% of portfolio in recently acquired operations, with 12 new construction projects underway, including a 40-bed addition achieving 98.3% occupancy.

**【CFO Financial Commentary】**
- **Q4 2025 financials**: GAAP EPS $1.61 (+18.4%), Adjusted EPS $1.82 (+22.1%). Full-year Adjusted EPS $6.57 (+19.5%). Cash flow from operations $564 million, supporting $500 million in strategic investments.
- **Balance sheet strength**: $504 million cash, $1 billion+ dry powder, and 1.77x lease-adjusted net debt/EBITDA. 2026 dividend increased for 23rd consecutive year.
- **2026 guidance**: $7.41-$7.61 EPS and $5.77-$5.84 billion revenue, driven by organic growth, acquisitions, and margin expansion.

**【Q&A Highlights】**
- **M&A pipeline**: Healthy pipeline with diverse sellers, including higher-priced strategic assets (e.g., Utah portfolio). 2026 focus on disciplined, value-accretive growth.
- **Labor improvements**: DON turnover down 33%, agency usage reduced, and overtime costs declining. South Bay Post Acute achieved 127% EBIT growth through clinical specialization.
- **Reimbursement strategy**: Strong performance in CMS value-based programs, with tools to adapt to regulatory changes. Behavioral health expansion in California, Arizona, and Texas.
- **Construction strategy**: Focused on high-demand projects like 40-bed behavioral health addition (98.3% occupancy) and replacement facilities to maintain market presence.


The Ensign Group, Inc. (ENSG) Q4 2025 Earnings Call Transcript

- **Record Quarter Growth**: 19.8% YoY revenue increase driven by 83% same-store occupancy and 5.1% skilled days growth.
- **Sustainable Expansion**: 2025 guidance raised to $6.54 EPS (18.4% YoY) as organic growth outpaces acquisitions.
- **Acquisition Discipline**: 2025 acquisitions of 1,857 beds closed at disciplined pricing, with 11-building CA portfolio already showing strong clinical improvement.
- **Behavioral Health Expansion**: Adding inpatient psych units to capture growing demand for high-acuity post-acute care.
- **Labor Stability**: Turnover below state averages, agency usage near pre-pandemic levels, wage inflation contained.

**【CEO Summary Section】**
- Reported a record quarter with strong clinical outcomes, driving same-store occupancy to 83% and transitioning occupancy to 84.4%, both all-time highs.
- Highlighted demographic tailwinds, with U.S. population aged 80+ projected to grow 50% by 2035, supporting demand for skilled nursing services.
- Skilled mix improvements: same-store skilled days up 5.1%, Medicare revenue up 10%, and managed care revenue up 7.1% year-over-year.
- Raised 2025 earnings guidance to $6.48-$6.54 per share (18.4% YoY growth) and revenue guidance to $5.05-$5.07 billion.

**【CFO Financial Commentary】**
- Q3 2025 GAAP EPS: $1.42 (6% YoY growth); Adjusted EPS: $1.64 (18% YoY growth).
- Consolidated revenue: $1.3 billion (19.8% YoY growth).
- Cash flows from operations: $381 million; available liquidity: $1.04 billion (cash + line of credit).
- Dividend of $0.0625 per share maintained; 22 consecutive years of dividend payments.

**【Q&A Key Highlights】**
- **Skilled Mix Growth Potential**: Same-store skilled days at 31.7% of total, with significant upside as facilities add higher acuity services (e.g., Beacon Harbor EBIT up 45% YoY).
- **Managed Care Expansion**: New markets like Alabama require 1-2 years to establish partnerships, but early results in Arizona (River Park Post Acute EBIT up 376% YoY) demonstrate rapid turnaround potential.
- **Acquisition Strategy**: Disciplined approach to pricing, avoiding overpriced deals; 2025 acquisitions include 11-building CA portfolio and 7-building UT portfolio, both performing ahead of expectations.
- **Behavioral Health**: Adding inpatient psych units in AZ and CA to meet demand from counties and managed care plans.
- **Labor Market**: Turnover below state averages, agency usage minimal (less than 1/5 of pre-pandemic levels), wage inflation stable at low-single digits.


The Ensign Group, Inc. (ENSG) Q3 2025 Earnings Call Transcript

- **Record Revenue Growth**: Q2 $1.2B (+18.5% YoY) with 2% same-store occupancy and 7.4% skilled mix gains. 2025 EPS guidance raised to $6.34-$6.46 (16.4% YoY growth).
- **Operational Excellence**: 12/17 acquired facilities achieve 4-5 star CMS ratings, 92%+ occupancy, 47% skilled mix. Eliminated 100% registry labor in transitioning facilities.
- **Financial Strength**: $364M cash, $228M operating cash flow, $1B+ dry powder. 22nd consecutive dividend increase.
- **Strategic Acquisitions**: 52 acquisitions since 2024, including 8 Q2 deals (710 beds). Disciplined portfolio approach with 1.5x+ EBITDAR coverage for third-party leases.
- **Regulatory Win**: Skilled nursing carve-out from provider tax reduction. State-level advocacy ensures Medicaid funding stability.


**【CEO Summary Section】**
- **Revenue Growth**: Q2 revenue reached $1.2 billion, up 18.5% YoY, driven by 2% and 4.6% increases in same-store and transitioning occupancy (82.1% and 84% respectively). Skilled census rose 7.4% and 13.5% for same-store and transitioning operations.
- **Operational Excellence**: Eliminated 100% of registry labor in transitioning facilities, with 92%+ occupancy and 47% skilled mix in recent large portfolio deals. 12/17 acquired facilities achieved 4-5 star CMS ratings.
- **Regulatory Win**: Skilled nursing carve-out from provider tax reduction in reconciliation bill. Raised 2025 EPS guidance to $6.34-$6.46 (16.4% YoY growth) and revenue to $4.99-$5.02 billion.

**【CFO Financial Commentary】**
- **Earnings**: GAAP EPS $1.44 (+18%), Adjusted EPS $1.59 (+20.5%). GAAP net income $84.4M (+18.9%), Adjusted net income $93.3M (+22.1%).
- **Liquidity**: $364M cash, $228M operating cash flow, $1B+ dry powder (including $593M credit line). 122 debt-free owned assets.
- **Dividend & Buyback**: $0.0625 quarterly dividend (22nd consecutive increase). Active stock repurchase program.

**【COO Operational Highlights】**
- **Sedona Trace (TX)**: 119-bed SNF acquired Q3 2021. Transformed from 2-star to 5-star quality, 34.3% skilled day growth, 130% EBIT increase. Eliminated registry labor, 95%+ occupancy.
- **Valley of the Moon (CA)**: 27-bed hospital-based SNF. Census up 250%, 0 registry labor, 5-star quality. Reduced hospital LOS and improved care continuity.

**【Q&A Key Highlights】**
- **Large Portfolio Strategy**: Success with 17-facility CA portfolio (split into 2-3 per cluster). 12/17 facilities >92% occupancy, 47% skilled mix. Pipeline includes multi-state portfolios with disciplined underwriting.
- **Third-Party Leasing**: 35/140 Standard Bearer assets leased to third parties. Target 1.5x+ EBITDAR coverage. Recent NW portfolio: 6/8 buildings leased to Ensign, 2 to third parties.
- **Medicaid Reimbursement**: California Workforce Program extended to 2026. Advocating for base rate alignment with quality programs. No immediate OBBB impact, but state-level funding conversations ongoing.
- **M&A Valuations**: Moderately rising prices post-COVID. Local teams drive deal evaluation based on DAR (days admitted residents). Passing on overpriced deals, closing 52 acquisitions since 2024.


Ensign Group (ENSG) Q2 2025 Earnings Call Transcript

- **Record Q1 Growth:** 16.1% YoY revenue rise to $1.2B, fueled by 19 new acquisitions (1,906 beds).\n- **Guidance Uptick:** EPS raised to $6.22-$6.38 (midpoint +14.5%), reflecting 82.6% same-store occupancy and 7.6% skilled census growth.\n- **Financial Strength:** $72.2M cash flow, $570M revolver availability, and 2.13x net debt/EBITDA.\n- **Operational Excellence:** Lomita facility saw 86.4% EBIT surge; Copperfield achieved 90.7% occupancy via ACO partnerships.\n- **Policy Resilience:** Advocacy efforts mitigate Medicaid risks; 5-star CMS ratings protect revenue.\n- **Leverage Potential:** 119 debt-free assets and $1B+ dry powder support disciplined expansion.\n

**【CEO Opening Remarks】**
- Q1 2025 revenue reached $1.2 billion, up 16.1% YoY, driven by same-store and transitioning operations.\n- Acquired 19 new operations (1,906 beds) across 8 states, including first entries in Alabama, Oregon, and Alaska.\n- Raised 2025 EPS guidance to $6.22-$6.38 (midpoint +14.5% YoY) and revenue to $4.89-$4.94 billion.\n- Emphasized disciplined growth strategy, prioritizing local leadership and accretive deals.\n
**【CFO Financial Highlights】**
- GAAP EPS: $1.37 (+15.1% YoY); Adjusted EPS: $1.52 (+16.9% YoY).\n- Cash flow from operations: $72.2 million; Free cash flow: $570 million available under revolver.\n- Invested $190 million in Q1, maintaining 2.13x net debt/EBITDA.\n- Dividend increased for 22nd consecutive year; $20M stock buyback completed.\n
**【COO Operational Success Stories】**
- **Lomita Post-Acute Care (CA):**\n  - Revenue +17.7%, EBIT +86.4%, Medicare days +19.8%, managed care days +85.7%.\n  - 5-star CMS ratings enabled stronger payer relationships.\n  - Turnover reduced 36%, lowering agency costs.\n- **Copperfield Healthcare (TX):**\n  - Occupancy 90.7% (+11% YoY), Medicare days +43%, managed care +14.8%.\n  - Partnered with ACOs to serve high-acuity patients, achieving 5-star quality measures.\n
**【Q&A Key Takeaways】**
- **Policy Risks:**\n  - Active advocacy in Washington; focus on protecting original Medicaid beneficiaries.\n  - Reassured Congress on impact of provider taxes and funding mechanisms.\n- **Staffing Dynamics:**\n  - Agency usage down, turnover improving; no admissions constraints despite macro labor shortages.\n  - Stability in wage inflation supports operating leverage.\n- **Market Expansion:**\n  - Southeast growth offset by lower labor costs; local leaders drive underwriting in new markets.\n  - 47 acquisitions since Q1 2024, with 137 owned properties generating $28.4M rental revenue.\n- **Capital Allocation:**\n  - $1B+ dry powder; 119 debt-free assets provide liquidity.\n  - Focused on accretive deals, not arbitrary growth targets.\n

The Ensign Group, Inc. (ENSG)-30 Apr 25-2025 Q1 Earnings call transcript

- **Revenue Growth**: Q4 2024 revenue up 15.5% YoY to $1.1 billion, with same-store occupancy +2.3% and transitioning occupancy +4.7% YoY.
- **2025 Guidance**: EPS of $6.16-$6.34 (13.8% midpoint growth) and revenue of $4.83-$4.91 billion, driven by 57 new 2024 acquisitions.
- **Operational Excellence**: Victoria Healthcare (CA) achieved 75.2% skilled mix, Boulder Canyon (CO) saw EBIT +131% YoY.
- **Balance Sheet Strength**: $464.6M cash, 1.9x net debt/EBITDA, $1B+ dry powder for M&A.
- **Medicaid Risks**: No broad-based cuts expected; Tennessee supplemental payments minimal vs. hospitals.
- **Labor Market**: Improving conditions + leadership development driving stability; California workforce standards fully modeled.


**【CEO Summary Section】**
- **Record Financial and Clinical Performance**: Q4 2024 revenue grew 15.5% YoY to $1.1 billion, with same-store occupancy up 2.3% and transitioning occupancy up 4.7% YoY. Managed care census increased 6.8% and 27.7% for same-store and transitioning operations, respectively.
- **2025 Guidance**: EPS of $6.16-$6.34 (13.8% midpoint growth vs. 2024) and revenue of $4.83-$4.91 billion. 5-year CAGR: 15.9% revenue, 25.6% EPS.
- **Acquisition Momentum**: Added 57 new operations in 2024, including 38 since Q1 2024. 2025 focus on disciplined growth in existing 15 states and cautious expansion into new markets like Alabama, Alaska, and Oregon.

**【CFO Financial Commentary】**
- **2024 Financial Highlights**: GAAP EPS $5.12 (+40.3%), revenue $4.3 billion (+14.2%). Q4 GAAP EPS $1.36 (+257.9%), revenue $1.1 billion (+15.5%).
- **Balance Sheet Strength**: $464.6 million cash, $347.2 million operating cash flow, 1.9x lease-adjusted net debt/EBITDA. $1 billion+ dry powder for M&A.
- **Dividend Growth**: 22nd consecutive year of dividend increases; Q4 dividend $0.0625/share.

**【COO Operational Success Stories】**
- **Victoria Healthcare (CA)**: Q4 2024 occupancy 95.9% (vs. 93% Q4 2023), skilled mix 75.2% (+420bps YoY). EBIT up 14% YoY.
- **Boulder Canyon (CO)**: Acquired 2021, Q4 2024 occupancy 84.4% (vs. <60% at acquisition). Skilled days +70%, managed care days +200%, EBIT +131% YoY.

**【M&A and Real Estate Update】**
- **Q4 2024 Acquisitions**: 12 new operations (1,147 beds) across Alabama, Tennessee, Wisconsin, Texas, Nebraska. 6 deals included real estate leased to Ensign affiliates via Standard Bearer.
- **Standard Bearer Growth**: 129 owned properties (97 leased to Ensign, 33 to third parties). Q4 rental revenue $25.1 million, FFO $15.3 million.

**【Q&A Key Takeaways】**
- **Medicaid Environment**: No immediate risks under new admin; focus on state-level advocacy. Tennessee supplemental payments minimal vs. hospital peers.
- **Labor Trends**: Improving market conditions + Ensign's leadership development driving stability. California workforce standards fully baked into 2025 guidance.
- **Cash Flow Dynamics**: Delays in Medicaid licensing approvals impacting short-term cash flow. Q4 2024 included one-time settlement payment.


Actual											0.77	0.73	0.78	0.8	0.87	0.89	0.91	0.97	0.99	1.01	1.04	1.1	1.13	1.16	1.2	1.28	1.3	1.32	1.39	1.49	1.52	1.59	1.64	1.82
Forecast											0.6125	0.5425	0.7275	0.78	0.835	0.88	0.9	0.962	0.968	1.002	1.042	1.098	1.085	1.14	1.19	1.275	1.285	1.3037	1.3782	1.4798	1.4916	1.5513	1.6126	1.7668
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+25.71%	+34.56%	+7.22%	+2.56%	+4.19%	+1.14%	+1.11%	+0.83%	+2.27%	+0.80%	-0.19%	+0.18%	+4.15%	+1.75%	+0.84%	+0.39%	+1.17%	+1.25%	+0.86%	+0.69%	+1.90%	+2.49%	+1.70%	+3.01%

ENSG

ENSG fundamentals

ENSG Q4 2025 Earnings

Earnings Call

You can ask Aime

ENSG

ENSG fundamentals

ENSG Q4 2025 Earnings

Earnings Call

ENSG Earnings Call Summary for Q4/20251:00 PM on Feb 5, 2026

ENSG Earnings Call Summary for Q3/20251:00 PM on Nov 4, 2025

ENSG Earnings Call Summary for Q2/20251:00 PM on Jul 25, 2025

ENSG Earnings Call Summary for Q1/20251:00 PM on Apr 30, 2025

ENSG Earnings Call Summary for Q4/20241:00 PM on Feb 6, 2025

You can ask Aime